Abstract Background Progressing the evaluation and management of Perianal fistulizing Crohn’s disease ( CD-pAF ) , an aggressive phenotype of CD , is one of the key unmet needs in Inflammatory Bowel Disease (IBD). There is sub-optimal understanding of the behavior of CD-pAF with some patients having rapid velocity of disease progression needing radical surgery such as proctectomy or diverting stoma. More recently, a practical patient-centric classification has been developed recently by Geldof et al has been used to classify patients underpinned by the behavior of CD-pAF(1). We aimed to evaluate the fistula class trajectory using Geldof classification in a large cohort of CD-pAF patients. Methods Data for 997 patients with Crohn’s disease perianal fistula (CD-pAF) included in a cohort study of patients with existing diagnosis of CD-pAF. Data was entered to predefined time points starting at the date of diagnosis of Cd-pAF and onward until entry into the cohort. We analysed the change in fistula classification using Geldof classification over 2 years. Results Data at entry to the cohort of 997 ( Males 52% , Females 48%) patients were included in the analysis The median age at fistula diagnosis was 31 years (23, 42). Among the 997 patients 686 had their Geldof class identified at baseline and 665 at 6-12 months. Class 2a followed by class 1 were the most frequent classes reported (Class 2a at baseline 376/686(55%) and Class 1 167/686(24%), at 6-12 months class 2a were 286/665(43%) and class 1 were 252/665(38%). At 12-24 months from fistula diagnosis 599 patients’ classes were reported, the most frequent being class 1 279/599(47%). There were minimal variations in Class 2b and class 2ci over the 3 time periods. (Class 2b [112/686(16%], [92/665(14%)]and [82/549(15%)] respectively, class 2ci [21/686(3%)], [20/665(3%)] [14/549(3%)] respectively). 15/686(2.1%) had proctectomy in the first 2 years. Conclusion While there are dynamic changes in fistula classification over 2 year period from fistula diagnosis there seems to be clustering among some classes. This indicates potential opportunity for identifying distinct classes which may have refractory course and tailor therapies accordingly. References (1)Geldof J, Iqbal N, LeBlanc JF, et al. Classifying perianal fistulising Crohn’s disease: an expert consensus to guide decision-making in daily practice and clinical trials. Lancet Gastroenterol Hepatol. 2022;7(6):576-584. doi:10.1016/S2468-1253(22)00007-3
Read full abstract